Kinase packing defects as drug targets.

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Protein kinases are key targets in cancer therapy.
• Kinase structural similarity leads to drug specificity issues and side effects.
• Developing specific kinase inhibitors is crucial for effective cancer treatment.

Purpose of the Study:

• To review novel drug design strategies for protein kinase inhibitors.
• To explore the use of packing defects as a molecular marker for drug specificity.
• To address challenges in paralogue discrimination, cross-reactivity, and drug resistance.

Main Methods:

• Survey of recent approaches in drug design.
• Analysis of molecular markers, specifically packing defects (solvent-exposed intramolecular hydrogen bonds).
• Review of design strategies for specificity and overcoming resistance.

Main Results:

• Packing defects offer a route to achieve high specificity in kinase inhibitors.
• Exploiting packing defects can help discriminate between kinase paralogues.
• This strategy aids in controlling cross-reactivity and overcoming drug resistance.

Conclusions:

• Targeting protein kinase packing defects is a promising strategy for developing safer and more effective cancer drugs.
• This approach can lead to improved paralogue discrimination and reduced off-target effects.
• Drug design exploiting packing defects holds potential for overcoming acquired drug resistance in cancer therapy.